Immutep Limited (ASX: IMM) Initiates Phase III Trial for Lung Cancer
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Mithril Silver and Gold Limited reports progress in its Copalquin project with a new drilling program and upcoming resource updates.
Integral Diagnostics secures ACCC approval for Capitol Health acquisition, requiring divestiture of a clinic in the Melton region.
Strata Minerals Limited (ASX:SMX) announces major advancements in gold, uranium, and rare earths exploration projects.
Cobalt Blue Holdings (ASX:COB) and Mount Isa City Council sign an MOU to address the looming sulphuric acid supply shortage in North West Queensland.
IRIS Metals successfully raises $8.01 million in capital, strengthening its lithium exploration initiatives and confirming a partnership with Stardust Power.
WA1 Resources Ltd announces positive results from niobium beneficiation testwork at the West Arunta Project.
Platinum Asset Management (ASX:PTM) declares a special dividend and concludes discussions with Regal while pursuing a turnaround strategy.
Elevate Uranium Limited (ASX:EL8) shares progress on exploration and upcoming U-pgrade⢠demonstration plant in Namibia.
Australian Rare Earths Limited secures a $5M grant to advance the Koppamurra Project, reinforcing its strategic position in the rare earth sector.